Lab test aims to Fine-Tune drug for preventing deadly Post-Birth bleeding
NCT ID NCT06930391
Summary
This is a laboratory study using donated uterine tissue to understand how calcium levels in the blood affect a key drug (carbetocin) used to prevent severe bleeding after a C-section. Researchers will test the drug's effectiveness under different calcium conditions to see if adjusting calcium could make the treatment work better. The goal is to gather knowledge that could lead to improved strategies for preventing and treating this serious childbirth complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE (PRIMARY) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, M5G1X5, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.